Reset MapGlenn Berge Building Babraham Research Park Cambridge CB22 3FH, United Kingdom, 27713 2849 United KingdomAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
5 Triangle Dr Durham, NC, 27713 2849 United StatesAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
2575 West Bellfort St., Suite 2001 Houston, TX 77054Accelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
31 Columbia Aliso Viejo, CA 92656Accelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
6 MorganAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
9490 NeoGenomics Way Fort Myers, FL, 33912 United StatesAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
7256 S. Sam Houston Pkwy W. Suite 300 Houston, TX, 77085 United StatesAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
12701 Commonwealth DriveAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
618 Grassmere Park DriveAccelerate Precision Oncology with a Trusted Biopharma Partner NeoGenomics empowers biopharma innovators to advance precision therapies from discovery through commercialization. Our integrated multi-modal testing, biomarker expertise, and real-world data insights help de-risk development, accelerate critical milestones, and bring transformative therapies to patients faster. Trusted by 300+ biopharma partners, including 85% of the top 20 • End-to-end multi-modal testing services through CAP-accredited and CLIA-certified laboratories in the United States and the United Kingdom. • Comprehensive, validated off-the-shelf assays and integrated data analysis. • Advanced customization for your program’s needs. • Experience across 25+ oncology indications, including solid, hematologic, and rare cancers. • Complimentary scientific consultation and strategic biomarker guidance. • Beyond lab data - de-risk your biomarker strategy with multi-modal real-world data and accelerate your timeline with qualified, timely patient insights and alerts. Core Capabilities Histopathology • Spatial Analysis • Genomics • Flow Cytometry • FISH & Cytogenetics • Multi-Modal Real-World Evidence
The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.
We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.
Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.
Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.
Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.
Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.
Scientist.com is a highly efficient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.
If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.
Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.